Efficiency metrics are a simple and effective medicinal chemistry tool to track small molecule progress toward a preferred profile in lead optimization. Targeted protein degradation can be mediated by small molecules that act as a molecular glue between an E3 ligase and a protein target. Molecular glue compounds are characterized by the potency and the depth of their protein degradation dose response measurement, representing additional complexity toward identifying drug candidates. We developed degradation efficiency metrics that are based on both potency and depth of degradation. They serve as basic scoring functions to effectively track lead optimization objectives. In recent years, applying machine learning (ML) has effectively accelera...
The lead optimization process has become a critical engine in identifying novel chemical entities fo...
Multicomponent reaction (MCR) chemistry is a promising and useful tool for building the chemical lib...
Predicting druggability and prioritising disease-modifying targets is critical in drug discovery. In...
Lead optimization is one of the important phases of Drug Discovery Process in which researchers desi...
During the past decade, decreasing the attrition rate of drug development candidates reaching the ma...
The prediction of compound properties from chemical structure is a main task for machine learning (M...
In medicinal chemistry, lead optimization is a critically important task and a highly empirical proc...
The use of composite metrics that normalise biological potency values in relation to markers of phys...
The judicious application of ligand or binding efficiency metrics, which quantify the molecular prop...
Fragment optimizations in nearly 150 fragment-based drug discovery programs reported in the literatu...
Targeted protein degradation with molecular glue degraders has arisen as a powerful therapeutic moda...
Lead Optimization is a complex process, whereby a large number of interacting entities give rise to ...
Polyanhydrides are a class of degradable biomaterials that have shown much promise for applications ...
Protein-protein interactions (PPIs) govern all biological processes. Some small molecules modulate P...
Predicting druggability and prioritising certain disease modifying targets is critical in drug disco...
The lead optimization process has become a critical engine in identifying novel chemical entities fo...
Multicomponent reaction (MCR) chemistry is a promising and useful tool for building the chemical lib...
Predicting druggability and prioritising disease-modifying targets is critical in drug discovery. In...
Lead optimization is one of the important phases of Drug Discovery Process in which researchers desi...
During the past decade, decreasing the attrition rate of drug development candidates reaching the ma...
The prediction of compound properties from chemical structure is a main task for machine learning (M...
In medicinal chemistry, lead optimization is a critically important task and a highly empirical proc...
The use of composite metrics that normalise biological potency values in relation to markers of phys...
The judicious application of ligand or binding efficiency metrics, which quantify the molecular prop...
Fragment optimizations in nearly 150 fragment-based drug discovery programs reported in the literatu...
Targeted protein degradation with molecular glue degraders has arisen as a powerful therapeutic moda...
Lead Optimization is a complex process, whereby a large number of interacting entities give rise to ...
Polyanhydrides are a class of degradable biomaterials that have shown much promise for applications ...
Protein-protein interactions (PPIs) govern all biological processes. Some small molecules modulate P...
Predicting druggability and prioritising certain disease modifying targets is critical in drug disco...
The lead optimization process has become a critical engine in identifying novel chemical entities fo...
Multicomponent reaction (MCR) chemistry is a promising and useful tool for building the chemical lib...
Predicting druggability and prioritising disease-modifying targets is critical in drug discovery. In...